NCT03917420View on ClinicalTrials.gov

Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI Tract

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

September 4, 2019

Study Completion Date

September 4, 2019

Conditions
HIV/AIDS
Interventions
DRUG

Tenofovir 300Mg Oral Tablet

Once daily dose of the combo tab x 5 days pre-sampling

DRUG

Emtricitabine 200 MG

Once daily dose of the combo tab x 5 days pre-sampling

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT03917420 - Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI Tract | Biotech Hunter | Biotech Hunter